Structural perspective on the design of selective DYRK1B inhibitors

Area of Science:

• Biochemistry
• Structural Biology
• Medicinal Chemistry

Background:

• Dual-specificity tyrosine-phosphorylation-regulated kinase 1B (DYRK1B) is implicated in oncology and non-alcoholic fatty liver disease.
• Lack of structural data for DYRK1B has hindered the development of selective inhibitors.

Purpose of the Study:

• To elucidate the structure of DYRK1B and identify features for selective inhibitor design.
• To provide a structural framework for developing targeted therapies with reduced off-target effects.

Main Methods:

• Multi-method approach including X-ray crystallography, biophysical analyses, and computational modeling.
• Determined crystal structures of DYRK1B and DYRK1A in complex with the inhibitor AZ191.
• Comparative analysis of DYRK1B and DYRK1A active site architecture.

Main Results:

• Reported the crystal structure of DYRK1B complexed with AZ191.
• Identified distinct features in the DYRK1B hinge-binding region crucial for kinase selectivity.
• Observed differences in catalytic lysine accessibility between DYRK1B and DYRK1A.

Conclusions:

• Structural insights into DYRK1B provide a basis for designing more selective inhibitors.
• Findings facilitate the development of targeted therapies for DYRK1B-related diseases.
• Understanding structural differences aids in minimizing off-target activity of DYRK1B inhibitors.